Related Experiment Videos
Rapid screening for HIV-1 protease inhibitor leads through X-ray diffraction
Bindu Pillai1, K K Kannan, S V Bhat
1Solid State Physics Division, Bhabha Atomic Research Centre, Trombay, Mumbai, India.
Summary
Structural insights into HIV-1 protease using hexagonal crystals and X-ray diffraction accelerate the development of AIDS drugs. This method rapidly identifies potential inhibitor leads for structure-based drug design.
Area of Science:
- Structural Biology
- Drug Discovery
- Virology
Background:
- Three-dimensional structures of HIV-1 protease and its inhibitor complexes are crucial for developing AIDS therapies.
- Understanding enzyme conformation is key to designing effective antiviral drugs.
Purpose of the Study:
- To evaluate the utility of hexagonal crystals of unliganded tethered HIV-1 protease for inhibitor lead identification.
- To assess the efficiency of the soaking method in structure-based drug design for HIV-1 protease.
Main Methods:
- Utilizing hexagonal crystals of unliganded tethered HIV-1 protease.
- Employing X-ray diffraction combined with the soaking method for structure determination.
- Comparing structures obtained via soaking with those from co-crystallization.
Main Results:
- The enzyme conformation in hexagonal crystals is identical to its ligand-bound state.
- The soaking method allows for rapid structure determination of HIV-1 protease-ligand complexes.
- Structures determined using the soaking method closely resemble those obtained through co-crystallization.
Conclusions:
- Hexagonal crystals of HIV-1 protease combined with the soaking method offer a rapid and general approach for structure-based drug design.
- This technique facilitates iterative drug design by quickly identifying potential inhibitor leads.
- The soaking method provides a viable alternative to co-crystallization for determining HIV-1 protease complex structures.